Search research articles
Contact Us
Filters
Showing results (81-90 of 180) with videos related to
Page
of 18
Sort By:
Breast Care (Basel, Switzerland)
|
September 9, 2010
Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor
Joachim Van Keirsbilck, Ine Riphagen, Hans Struyven, et al.
Journal of Translational Medicine
|
June 25, 2014
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations
Mutsa T Madondo, Sandra Tuyaerts, Brit B Turnbull, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study
Ignace Vergote, Frederic Amant, Gülten Oskay-Oezcelik, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 19, 2019
FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study
Marie Plante, Nienke van Trommel, Stephanie Lheureux, et al.
The Oncologist
|
June 26, 2024
High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer
Lilian van Wagensveld, Tom Van Nyen, Daniela Annibali, et al.
BMC Cancer
|
January 24, 2008
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
Olivier Gevaert, Frank De Smet, Toon Van Gorp, et al.
Gynecologic Oncology
|
June 24, 2005
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer
Frederic Amant, Isabelle Cadron, Luca Fuso, et al.
Gynecologic Oncology
|
June 16, 2004
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
Frederic Amant, Katrien Schurmans, Edwin Steenkiste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2009
Reproduction rates after cytotoxic therapy
Birgit Mispelaere, Evelyn Van de Werf, Thomas D'Hooghe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 24, 2012
Pelvic exenterations for gynecological malignancies: a study of 36 cases
Manpreet Kaur, Steven Joniau, André D'Hoore, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 180) with videos related to
Sort By:
Page
of 18
Breast Care (Basel, Switzerland)
|
September 9, 2010
Bilateral Mammary Tuberculosis Associated with a Borderline Ovarian Tumor
Joachim Van Keirsbilck, Ine Riphagen, Hans Struyven, et al.
Journal of Translational Medicine
|
June 25, 2014
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations
Mutsa T Madondo, Sandra Tuyaerts, Brit B Turnbull, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Carboplatin and paclitaxel in combination with oral enzastaurin in advanced ovarian or primary peritoneal cancer: results from a safety lead-in study
Ignace Vergote, Frederic Amant, Gülten Oskay-Oezcelik, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 19, 2019
FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study
Marie Plante, Nienke van Trommel, Stephanie Lheureux, et al.
The Oncologist
|
June 26, 2024
High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer
Lilian van Wagensveld, Tom Van Nyen, Daniela Annibali, et al.
BMC Cancer
|
January 24, 2008
Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation
Olivier Gevaert, Frank De Smet, Toon Van Gorp, et al.
Gynecologic Oncology
|
June 24, 2005
Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer
Frederic Amant, Isabelle Cadron, Luca Fuso, et al.
Gynecologic Oncology
|
June 16, 2004
Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma
Frederic Amant, Katrien Schurmans, Edwin Steenkiste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2009
Reproduction rates after cytotoxic therapy
Birgit Mispelaere, Evelyn Van de Werf, Thomas D'Hooghe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 24, 2012
Pelvic exenterations for gynecological malignancies: a study of 36 cases
Manpreet Kaur, Steven Joniau, André D'Hoore, et al.
Page
of 18